Human milk fortifier for Premature Birth

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Premature BirthHuman milk fortifier - DietarySupplement
Eligibility
< 18
All Sexes
What conditions do you have?
Select

Study Summary

This trial will test whether human milk fortifier given on day 1 helps improve growth velocity at 28 days and 36 weeks post menstrual age.

Eligible Conditions
  • Premature Birth

Treatment Effectiveness

Study Objectives

0 Primary · 1 Secondary · Reporting Duration: at 36 weeks post menstrual age

Week 36
Growth velocity

Trial Safety

Trial Design

2 Treatment Groups

Control
1 of 2
Intervention
1 of 2

Active Control

Experimental Treatment

50 Total Participants · 2 Treatment Groups

Primary Treatment: Human milk fortifier · No Placebo Group · N/A

Intervention
DietarySupplement
Experimental Group · 1 Intervention: Human milk fortifier · Intervention Types: DietarySupplement
ControlNoIntervention Group · 1 Intervention: Control · Intervention Types:
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Human milk fortifier
2011
N/A
~190

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: at 36 weeks post menstrual age

Who is running the clinical trial?

Augusta UniversityLead Sponsor
193 Previous Clinical Trials
74,111 Total Patients Enrolled

Eligibility Criteria

Age < 18 · All Participants · 3 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have a birth weight of 1000-1500 grams.\n
You are admitted to the NICU within 24 hours of birth.